4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-046683
Chief Medical Officer sold 2,631 shares at $16.98 ($44,675)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gordon David N. Chief Medical Officer | 2021-07-13 | Sale | −2,631 | $16.98 | $44,675 | 147,447 | D: show line 1 in the form |
| Open-market sales · 2,631 sh · avg $16.98 · $44,675 | |||||||
Loading xslF345X03/doc4.xml…